Clinical trial
A Retrospective Study to Analyze Efficacy of COVID-19 Treatments
NCT04949230 is registered in ClinicalTrials.gov with ProgenaBiome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Study to Analyze Efficacy of COVID-19 Treatments
- Lead sponsor
- ProgenaBiome
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 19, 2021
- Completion date
- February 15, 2024
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 acute bronchitis, covid-19 acute respiratory distress syndrome, covid-19 lower respiratory infection, covid-19 pneumonia, covid-19 respiratory infection, covid19, sars-cov-2 acute respiratory disease, sars-cov2 infection